C. Olbrich

发表

Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer.

R. Müller, M. Sameti, C. Lehr, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA.

R. Müller, U. Bakowsky, C. Lehr, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes.

R. Müller, M. Sameti, U. Bakowsky, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Solid Lipid Nanoparticles: Interaction with Cells,Cytokine Production, and Enzymatic Degradation

K. Tabatt, C. Olbrich, S. Wissing, 2004 .

Optical imaging in drug discovery and diagnostic applications.

C. Olbrich, K. Licha, 2005, Advanced drug delivery reviews.

The in vitro stability of air-filled polybutylcyanoacrylate microparticles.

M. Schirner, U. Bakowsky, C. Olbrich, 2006, Biomaterials.

Lipid-Drug-Conjugate (LDC) Nanoparticles as Novel Carrier System for the Hydrophilic Antitrypanosomal Drug Diminazenediaceturate

R. Müller, O. Kayser, C. Olbrich, 2002, Journal of drug targeting.

Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs

S. Croft, O. Kayser, A. Kiderlen, 2003, Parasitology Research.

Polymeric micelles for parenteral delivery of sagopilone: physicochemical characterization, novel formulation approaches and their toxicity assessment in vitro as well as in vivo.

T. Kissel, C. Olbrich, J. Hoffmann, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption.

R. Müller, O. Kayser, W. Schröder, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)--effect of surfactants, storage time and crystallinity.

R. Müller, O. Kayser, C. Olbrich, 2002, International journal of pharmaceutics.

Enzymatic Degradation of Dynasan 114 SLN – Effect of Surfactants and Particle Size

R. Müller, O. Kayser, C. Olbrich, 2002 .

The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles.

R. Müller, O. Kayser, W. Schröder, 2001, International journal of pharmaceutics.

Non-ionic dendritic glycerol-based amphiphiles: novel excipients for the solubilization of poorly water-soluble anticancer drug Sagopilone.

R. Haag, T. Kissel, C. Olbrich, 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Formulation of amphotericin B as nanosuspension for oral administration.

C Olbrich, V. Yardley, S. Croft, 2003, International journal of pharmaceutics.

Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages.

R. Müller, H. Hahn, K. Tabatt, 2001, International journal of pharmaceutics.

Thermally induced degradation pathways of three different antibody-based drug development candidates.

Jonas P. Winter, C. Olbrich, T. Bunte, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Solubilization of sagopilone, a poorly water-soluble anticancer drug, using polymeric micelles for parenteral delivery.

Thomas Kissel, T. Kissel, C. Olbrich, 2010, International journal of pharmaceutics.

Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages—impact of phagocytosis on viability and cytokine production

R. Müller, O. Kayser, K. Tabatt, 2004, The Journal of pharmacy and pharmacology.

Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.

R. Müller, C. Olbrich, 1999, International journal of pharmaceutics.

A Real-Time in Vitro Assay for Studying Functional Characteristics of Target-Specific Ultrasound Contrast Agents

M. Schirner, C. Olbrich, A. Briel, 2004, Pharmaceutical Research.

Specific targeting of ultrasound contrast agent (USCA) for diagnostic application: an in vitro feasibility study based on SAW biosensor.

Eckhard Quandt, Michael Famulok, Michael Schirner, 2005, Biosensors & bioelectronics.

Stable Biocompatible Adjuvants — a New Type of Adjuvant Based on Solid Lipid Nanoparticles: A Study on Cytotoxicity, Compatibility and Efficacy in Chicken

R. Müller, O. Kayser, K. Tabatt, 2002, Alternatives to laboratory animals : ATLA.

SOLID LIPID NANOPARTICLES : PHAGOCYTIC UPTAKE, IN VITRO CYTOTOXICITY AND IN VITRO BIODEGRADATION : 1ST COMMUNICATION

C. Olbrich, R. Muller, 1999 .